D2.07 final report on tools and systems to guide appropriate use of medicinal products in twelve EU Member States

The objective of D2.07 was to provide an overview of which tools and systems are available at the national level to guide the appropriate use of medicinal products in EU Member States. This report looks at all tools/systems for guiding appropriate use at the national level, even if these may not be directly applicable in the context of a MAPPs-type pathway.

D2.07 final report on tools and systems to guide appropriate use of medicinal products in twelve EU Member States 2017-12-18T14:50:43+00:00

Joint workshop on tools and systems used for prescription control (D2.07) & the ethical and legal aspects of adaptive decision making (D3.09)

On the 17th of January 2017, as part of its Annual Meeting, the ADAPT SMART consortium hosted a multi-stakeholder workshop on ‘Tools and systems used for prescription control and the ethical and legal aspects of adaptive decision making’. The topic of this workshop related to two different deliverables: D2.07 (focused on prescription control) and D3.09 (focused on ethical and legal aspects of adaptive decision making).

Joint workshop on tools and systems used for prescription control (D2.07) & the ethical and legal aspects of adaptive decision making (D3.09) 2017-08-03T08:49:34+00:00

Seamless Process and Decision Points of an Adaptive Pathway

This report proposes a framework with pictographic representation of an adaptive pathway containing key moments, events and involved stakeholders, in each phase. This model is purposefully presented rather simplistically in this first evolution, acknowledging that there remain several questions to be answered – both unique to each individual potential medicine as well as to full implementation of an integrated adaptive pathway approach.

Seamless Process and Decision Points of an Adaptive Pathway 2017-06-26T13:36:10+00:00

Discussion paper on Engagement Criteria for MAPPs

An issue of divergent views became apparent early in the course of the ADAPT SMART project, namely; to what kind of novel medicines and clinical scenarios/conditions should a MAPPs approach be applied? The ADAPT SMART consortium convened discussion fora with stakeholders to elaborate MAPPs engagement criteria that may be acceptable to all concerned within the existing legislation. In this paper, we summarize viewpoints from these discussions.

Discussion paper on Engagement Criteria for MAPPs 2017-06-20T11:17:45+00:00

ADAPT SMART Glossary

The ADAPT SMART glossary provides working definitions for common terms relevant for the consortium and includes references. The glossary is based on the input from members of the ADAPT SMART consortium representing different stakeholder groups. The definitions are based on relevant legislation or literature sources and written in the context of the ADAPT SMART project; where applicable, [...]

ADAPT SMART Glossary 2017-03-08T09:07:33+00:00

Blog From D2.03 Leaders: Takeaways From the ADAPT SMART Workshop on Selection Criteria for MAPPs

On the 29th of February, ADAPT SMART hosted an invitation-only multi-stakeholder workshop around selection criteria for MAPPs in Amsterdam, The Netherlands. Angelika Joos of MSD and Mathieu Boudes of EURORDIS attended the workshop in their capacity as ADAPT SMART Task 2.03 leaders. Here they share an update on the workshop’s progress. More information about the workshop can [...]

Blog From D2.03 Leaders: Takeaways From the ADAPT SMART Workshop on Selection Criteria for MAPPs 2017-06-20T11:17:46+00:00